Masakazu Notsu

732 total citations
39 papers, 558 citations indexed

About

Masakazu Notsu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Orthopedics and Sports Medicine. According to data from OpenAlex, Masakazu Notsu has authored 39 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Orthopedics and Sports Medicine. Recurrent topics in Masakazu Notsu's work include Bone Metabolism and Diseases (15 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (9 papers). Masakazu Notsu is often cited by papers focused on Bone Metabolism and Diseases (15 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (9 papers). Masakazu Notsu collaborates with scholars based in Japan. Masakazu Notsu's co-authors include Toshitsugu Sugimoto, Ippei Kanazawa, Ayumu Takeno, Ken‐ichiro Tanaka, Ken-ichiro Tanaka, Toru Yamaguchi, Mika Yamauchi, Masahiro Yamamoto, Shozo Yano and Sayuri Tanaka and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Masakazu Notsu

38 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masakazu Notsu Japan 15 242 151 140 115 90 39 558
Yuichi Takashi Japan 18 313 1.3× 217 1.4× 71 0.5× 157 1.4× 115 1.3× 51 890
Tatiana Kouznetsova United States 10 166 0.7× 74 0.5× 151 1.1× 60 0.5× 60 0.7× 20 498
Pedro Rozas-Moreno Spain 13 376 1.6× 190 1.3× 370 2.6× 203 1.8× 88 1.0× 32 879
Ayumu Takeno Japan 14 142 0.6× 55 0.4× 63 0.5× 113 1.0× 77 0.9× 28 379
Cristina Alonso‐Montes Spain 15 302 1.2× 37 0.2× 62 0.4× 78 0.7× 80 0.9× 39 851
Katrine Hygum Denmark 8 204 0.8× 141 0.9× 263 1.9× 125 1.1× 90 1.0× 11 484
Laura Piacente Italy 13 233 1.0× 55 0.4× 104 0.7× 94 0.8× 28 0.3× 25 523
Marcel Fourcaudot United States 11 312 1.3× 160 1.1× 61 0.4× 40 0.3× 158 1.8× 22 592
Linjian Mo China 15 183 0.8× 143 0.9× 56 0.4× 85 0.7× 43 0.5× 27 568
Britt Opdebeeck Belgium 10 187 0.8× 73 0.5× 55 0.4× 40 0.3× 72 0.8× 18 568

Countries citing papers authored by Masakazu Notsu

Since Specialization
Citations

This map shows the geographic impact of Masakazu Notsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Notsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Notsu more than expected).

Fields of papers citing papers by Masakazu Notsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Notsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Notsu. The network helps show where Masakazu Notsu may publish in the future.

Co-authorship network of co-authors of Masakazu Notsu

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Notsu. A scholar is included among the top collaborators of Masakazu Notsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Notsu. Masakazu Notsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Notsu, Masakazu, et al.. (2023). Association Between Papillary Thyroid Carcinoma and Vertebral Fracture. Hormone and Metabolic Research. 55(9). 592–598. 1 indexed citations
2.
Notsu, Masakazu, et al.. (2020). Graves’ disease and vertebral fracture: Possible pathogenic link in postmenopausal women. Clinical Endocrinology. 93(2). 204–211. 8 indexed citations
3.
Morita, Miwa, Hitomi Miyake, Masahiro Yamamoto, et al.. (2020). A case of insulin-like growth factor 2-producing gastrointestinal stromal tumor with severe hypoglycemia. BMC Endocrine Disorders. 20(1). 60–60. 10 indexed citations
4.
Takeno, Ayumu, Ippei Kanazawa, Ken‐ichiro Tanaka, et al.. (2020). High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation. Diabetology International. 12(2). 171–180. 10 indexed citations
5.
Kanazawa, Ippei, et al.. (2019). A scoring assessment tool for the risk of vertebral fractures in patients with type 2 diabetes mellitus. Bone. 122. 38–44. 6 indexed citations
6.
Takeno, Ayumu, Ippei Kanazawa, Ken‐ichiro Tanaka, Masakazu Notsu, & Toshitsugu Sugimoto. (2019). Phloretin Suppresses Bone Morphogenetic Protein-2-Induced Osteoblastogenesis and Mineralization via Inhibition of Phosphatidylinositol 3-kinases/Akt Pathway. International Journal of Molecular Sciences. 20(10). 2481–2481. 19 indexed citations
7.
Notsu, Masakazu, Ippei Kanazawa, Ayumu Takeno, Ken‐ichiro Tanaka, & Toshitsugu Sugimoto. (2019). Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis via NADPH Oxidase-Interleukin 1β and 6 Pathway in Osteocyte-like Cells. Calcified Tissue International. 105(4). 446–457. 2 indexed citations
8.
Kanazawa, Ippei, Ken‐ichiro Tanaka, Ayumu Takeno, et al.. (2019). Insulin-Like Growth Factor-I Protects Against the Detrimental Effects of Advanced Glycation End Products and High Glucose in Myoblastic C2C12 Cells. Calcified Tissue International. 105(1). 89–96. 16 indexed citations
9.
Takeno, Ayumu, Ippei Kanazawa, Masakazu Notsu, Ken‐ichiro Tanaka, & Toshitsugu Sugimoto. (2018). Phloretin Promotes Adipogenesis via Mitogen-Activated Protein Kinase Pathways in Mouse Marrow Stromal ST2 Cells. International Journal of Molecular Sciences. 19(6). 1772–1772. 21 indexed citations
10.
11.
Notsu, Masakazu, Miwa Morita, Masahiro Yamamoto, et al.. (2018). Acute suppurative thyroiditis caused by thyroid papillary carcinoma in the right thyroid lobe of a healthy woman. Thyroid Research. 11(1). 4–4. 2 indexed citations
12.
Takeno, Ayumu, Ippei Kanazawa, Masakazu Notsu, Ken‐ichiro Tanaka, & Toshitsugu Sugimoto. (2017). Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells. American Journal of Physiology-Endocrinology and Metabolism. 314(2). E115–E123. 17 indexed citations
13.
Kanazawa, Ippei, Ayumu Takeno, Ken‐ichiro Tanaka, Masakazu Notsu, & Toshitsugu Sugimoto. (2017). Osteoblast AMP-Activated Protein Kinase Regulates Postnatal Skeletal Development in Male Mice. Endocrinology. 159(2). 597–608. 16 indexed citations
14.
15.
Kanazawa, Ippei, Ken-ichiro Tanaka, Masakazu Notsu, et al.. (2016). Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment. Diabetes Research and Clinical Practice. 123. 9–17. 20 indexed citations
16.
Takeno, Ayumu, Ippei Kanazawa, Ken‐ichiro Tanaka, et al.. (2016). Simvastatin rescues homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by decreasing the expressions of NADPH oxidase 1 and 2. Endocrine Journal. 63(4). 389–395. 13 indexed citations
17.
18.
Yokomoto‐Umakoshi, Maki, Ippei Kanazawa, Ayumu Takeno, et al.. (2015). Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cells. Biochemical and Biophysical Research Communications. 469(4). 791–796. 17 indexed citations
19.
Notsu, Masakazu & Toru Yamaguchi. (2013). [Secondary osteoporosis or secondary contributors to bone loss in fracture. Effects of oxidative stress on bone metabolism].. PubMed. 23(9). 1285–92. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Takashi Breakdown of academic impact, for papers by Tatiana Kouznetsova Breakdown of academic impact, for papers by Pedro Rozas-Moreno Breakdown of academic impact, for papers by Ayumu Takeno Breakdown of academic impact, for papers by Cristina Alonso‐Montes Breakdown of academic impact, for papers by Katrine Hygum Breakdown of academic impact, for papers by Laura Piacente Breakdown of academic impact, for papers by Marcel Fourcaudot Breakdown of academic impact, for papers by Linjian Mo Breakdown of academic impact, for papers by Britt Opdebeeck
Rankless by CCL
2026